High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$828K
$828,950
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| NAMS |
NewAmsterdam Pharma Co N.V.
|
Director
Other
|
2026-03-09 | $513,118 | X | Form 4 |
| NAMS |
NewAmsterdam Pharma Co N.V.
|
Director
Discretionary Sell
|
2026-03-06 | $828,950 | S | Form 4 |